HS
HighVista Strategies’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Buy |
68,652
+23,903
| +53% | +$790K | 0.83% | 34 |
|
|
2025
Q1 | $1.8M | Buy |
44,749
+30,488
| +214% | +$1.23M | 0.69% | 51 |
|
|
2024
Q4 | $671K | Buy |
14,261
+4,206
| +42% | +$198K | 0.25% | 118 |
|
|
2024
Q3 | $531K | Buy |
+10,055
| New | +$531K | 0.18% | 126 |
|
|
2022
Q4 | – | Sell |
-73,154
| Closed | -$3.54M | – | 109 |
|
|
2022
Q3 | $3.54M | Buy |
73,154
+5,652
| +8% | +$274K | 2.02% | 12 |
|
|
2022
Q2 | $2.65M | Buy |
67,502
+1,733
| +3% | +$68.1K | 1.6% | 19 |
|
|
2022
Q1 | $2.42M | Buy |
65,769
+30,537
| +87% | +$1.12M | 1.54% | 18 |
|
|
2021
Q4 | $1.61M | Buy |
+35,232
| New | +$1.61M | 1.28% | 19 |
|
|
2021
Q1 | – | Sell |
-47,520
| Closed | -$987K | – | 130 |
|
|
2020
Q4 | $987K | Buy |
+47,520
| New | +$987K | 0.63% | 27 |
|